版本:
中国

BRIEF-3Sbio Inc enters distribution and promotion agreement with two subsidiaries of Eli Lilly

May 16 3sbio Inc

* Enters distribution and promotion agreement with two subsidiaries of Eli Lilly and co for distribution and promotion of insulin products

* Co has been granted exclusive right of distribution and promotion of Humulin, an insulin product of Lilly, in China from July 1, 2017

* 3Sbio will establish a marketing and promotion team which will cover a wide array of diabetes products, including Humulin Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐